Unexpected ketamine effect in a patient with cervical dystonia.

作者信息

Nencini Cecilia, De Santis Vincenzo, Fusari Maurizio

机构信息

Department of Anesthesia and Intensive Care Medicine, Azienda Ospedaliera Santa Maria Delle Croci, AUSL Romagna, Viale Randi 5, 48121, Ravenna, Italy.

出版信息

J Neurol. 2021 Feb;268(2):712-713. doi: 10.1007/s00415-020-10326-3. Epub 2021 Jan 2.

DOI:10.1007/s00415-020-10326-3

PMID:33388925

Abstract

摘要

相似文献

Unexpected ketamine effect in a patient with cervical dystonia.

J Neurol. 2021 Feb;268(2):712-713. doi: 10.1007/s00415-020-10326-3. Epub 2021 Jan 2.

Dysport produces intrinsically more swallowing problems than Botox: unexpected results from a conversion factor study in cervical dystonia.

J Neurol Neurosurg Psychiatry. 2002 Nov;73(5):604; author reply 604. doi: 10.1136/jnnp.73.5.604.

Botulinum toxin type B for cervical dystonia.

Cochrane Database Syst Rev. 2005 Jan 25(1):CD004315. doi: 10.1002/14651858.CD004315.pub2.

Botulinum toxin treatment of axial and cervical dystonia.

Disabil Rehabil. 2007 Dec 15;29(23):1769-77. doi: 10.1080/01421590701568262.

Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia.

Drugs. 2002;62(4):705-22. doi: 10.2165/00003495-200262040-00011.

Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.

Clin Ther. 2007 Jul;29(7):1325-37. doi: 10.1016/j.clinthera.2007.07.020.

Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.

Headache. 2012 Sep;52(8):1219-25. doi: 10.1111/j.1526-4610.2012.02164.x. Epub 2012 May 18.

The safety and tolerability of botulinum toxins for the treatment of cervical dystonia.

Expert Opin Drug Saf. 2005 Mar;4(2):241-9. doi: 10.1517/14740338.4.2.241.

Is Botulinum Toxin Type A Efficacious, Safe, and Tolerable in Cervical Dystonia?: A Cochrane Review Summary With Commentary.

Am J Phys Med Rehabil. 2020 Jul;99(7):649-651. doi: 10.1097/PHM.0000000000001437.

Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.

Cochrane Database Syst Rev. 2005 Jan 25(1):CD004314. doi: 10.1002/14651858.CD004314.pub2.

引用本文的文献

Effects of subanesthetic dose of ketamine on motor and cognitive outcomes of harmaline-induced essential tremor model: a focus on Lingo-1 and inflammatory pathways.

BMC Neurosci. 2025 Aug 1;26(1):49. doi: 10.1186/s12868-025-00966-4.

本文引用的文献

Defining research priorities in dystonia.

Neurology. 2020 Mar 24;94(12):526-537. doi: 10.1212/WNL.0000000000009140. Epub 2020 Feb 25.

What is the role of the cerebellum in the pathophysiology of dystonia?

J Neurol. 2019 Jun;266(6):1549-1551. doi: 10.1007/s00415-019-09344-7.

Quality of life in idiopathic dystonia: a systematic review.

J Neurol. 2019 Dec;266(12):2897-2906. doi: 10.1007/s00415-018-9119-x. Epub 2018 Nov 20.

Oral ketamine for the treatment of pain and treatment-resistant depression†.

Br J Psychiatry. 2016 Feb;208(2):108-13. doi: 10.1192/bjp.bp.115.165498.

Role of striatal NMDA receptor subunits in a model of paroxysmal dystonia.

Exp Neurol. 2014 Nov;261:677-84. doi: 10.1016/j.expneurol.2014.08.012. Epub 2014 Aug 17.

Phenomenology and classification of dystonia: a consensus update.

Mov Disord. 2013 Jun 15;28(7):863-73. doi: 10.1002/mds.25475. Epub 2013 May 6.

Alterations in N-methyl-D-aspartate receptor binding in dystonic hamster brains.

Brain Res. 1997 Jan 2;744(1):161-5. doi: 10.1016/s0006-8993(96)01209-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Unexpected ketamine effect in a patient with cervical dystonia.

J Neurol. 2021 Feb;268(2):712-713. doi: 10.1007/s00415-020-10326-3. Epub 2021 Jan 2.

Dysport produces intrinsically more swallowing problems than Botox: unexpected results from a conversion factor study in cervical dystonia.

J Neurol Neurosurg Psychiatry. 2002 Nov;73(5):604; author reply 604. doi: 10.1136/jnnp.73.5.604.

Botulinum toxin type B for cervical dystonia.

Cochrane Database Syst Rev. 2005 Jan 25(1):CD004315. doi: 10.1002/14651858.CD004315.pub2.

Botulinum toxin treatment of axial and cervical dystonia.

Disabil Rehabil. 2007 Dec 15;29(23):1769-77. doi: 10.1080/01421590701568262.

Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia.

Drugs. 2002;62(4):705-22. doi: 10.2165/00003495-200262040-00011.

Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.

Clin Ther. 2007 Jul;29(7):1325-37. doi: 10.1016/j.clinthera.2007.07.020.

Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.

Headache. 2012 Sep;52(8):1219-25. doi: 10.1111/j.1526-4610.2012.02164.x. Epub 2012 May 18.

The safety and tolerability of botulinum toxins for the treatment of cervical dystonia.

Expert Opin Drug Saf. 2005 Mar;4(2):241-9. doi: 10.1517/14740338.4.2.241.

Is Botulinum Toxin Type A Efficacious, Safe, and Tolerable in Cervical Dystonia?: A Cochrane Review Summary With Commentary.

Am J Phys Med Rehabil. 2020 Jul;99(7):649-651. doi: 10.1097/PHM.0000000000001437.

Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.

Cochrane Database Syst Rev. 2005 Jan 25(1):CD004314. doi: 10.1002/14651858.CD004314.pub2.

引用本文的文献

Effects of subanesthetic dose of ketamine on motor and cognitive outcomes of harmaline-induced essential tremor model: a focus on Lingo-1 and inflammatory pathways.

BMC Neurosci. 2025 Aug 1;26(1):49. doi: 10.1186/s12868-025-00966-4.

本文引用的文献

Defining research priorities in dystonia.

Neurology. 2020 Mar 24;94(12):526-537. doi: 10.1212/WNL.0000000000009140. Epub 2020 Feb 25.

What is the role of the cerebellum in the pathophysiology of dystonia?

J Neurol. 2019 Jun;266(6):1549-1551. doi: 10.1007/s00415-019-09344-7.

Quality of life in idiopathic dystonia: a systematic review.

J Neurol. 2019 Dec;266(12):2897-2906. doi: 10.1007/s00415-018-9119-x. Epub 2018 Nov 20.

Oral ketamine for the treatment of pain and treatment-resistant depression†.

Br J Psychiatry. 2016 Feb;208(2):108-13. doi: 10.1192/bjp.bp.115.165498.

Role of striatal NMDA receptor subunits in a model of paroxysmal dystonia.

Exp Neurol. 2014 Nov;261:677-84. doi: 10.1016/j.expneurol.2014.08.012. Epub 2014 Aug 17.

Phenomenology and classification of dystonia: a consensus update.

Mov Disord. 2013 Jun 15;28(7):863-73. doi: 10.1002/mds.25475. Epub 2013 May 6.

Alterations in N-methyl-D-aspartate receptor binding in dystonic hamster brains.

Brain Res. 1997 Jan 2;744(1):161-5. doi: 10.1016/s0006-8993(96)01209-7.